An Observational Study of Patients With Dermatologic Disease
for Vitiligo
Sites in Philadelphia +2 more locations
Sponsor: Target PharmaSolutions, Inc.
Sex: All·Age: All ages
Code: NCT07748169·Recruiting·Listed Aug 5, 2026
Autoimmune disease Clinical Trials in Philadelphia, PA
As of August 2026, 42 paid clinical trials are recruiting for Autoimmune disease in Philadelphia, Pennsylvania. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Philadelphia
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
43 clinical trials for Autoimmune disease
·Clear filters· Email me when a new autoimmune disease trial opens in Philadelphia, PA.
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
Drug: Duvakitug
Sites in Philadelphia, Hershey +116 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for Crohn Disease
Sites in Philadelphia, Hershey +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Duvakitug
Sites in Philadelphia, Pittsburgh +92 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for Crohn's Disease
Drug: Tulisokibart
Sites in Philadelphia, Hershey +69 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 16 - 80
Code: NCT06430801·Phase 3·Recruiting·Listed May 2024
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for Ulcerative Colitis
Drug: Tirzepatide
Sites in Philadelphia +36 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 70
Code: NCT06937086·Phase 3·Recruiting·Listed Apr 2025
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for Crohn's Disease
Drug: Tirzepatide
Sites in Philadelphia +34 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 70
Code: NCT06937099·Phase 3·Recruiting·Listed Apr 2025
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for Crohn's Disease
Sites in Philadelphia +55 more locations
Sponsor: AbbVie
Sex: All·Age: 18 - 75
Code: NCT06548542·Phase 2·Recruiting·Listed Aug 2024
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
for Atopic Dermatitis
Drug: PF-07275315
Sites in Philadelphia +42 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT05995964·Phase 2·Recruiting·Listed Aug 2023
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for Atopic Dermatitis
Drug: Upadacitinib
Sites in Philadelphia, Plymouth Meeting +64 more locations
Sponsor: AbbVie
Sex: All·Age: 18 - 63
Code: NCT06389136·Phase 3·Recruiting·Listed Apr 2024
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
for Atopic Dermatitis
Drug: Nemolizumab
Sites in Philadelphia +57 more locations
Sponsor: Galderma R&D
Sex: All·Age: 12+
Code: NCT06988605·Recruiting·Listed May 2025
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for Generalized Myasthenia Gravis
Sites in Philadelphia +31 more locations
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT04202341·Recruiting·Listed Dec 2019
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
for Psoriatic Arthritis
Drug: Tulisokibart
Sites in Philadelphia, Duncansville +16 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18 - 80
Code: NCT07486960·Phase 2·Recruiting·Listed Mar 2026
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
for Psoriasis
Sites in Philadelphia +19 more locations
Sponsor: InventisBio Co., Ltd
Sex: All·Age: 18 - 70
Code: NCT07489885·Phase 2·Recruiting·Listed Mar 2026
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
for Hidradenitis Suppurativa
Drug: Ruxolitinib
Sites in Philadelphia +18 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 12 - 75
Code: NCT07049575·Phase 1·Recruiting·Listed Jul 2025
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
for Ulcerative Colitis
Drug: Risankizumab
Sites in Philadelphia, Pittsburgh +9 more locations
Sponsor: AbbVie
Sex: All·Age: 2 - 17
Code: NCT07071519·Phase 3·Recruiting·Listed Jul 2025
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Duvakitug
Sites in Philadelphia +21 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184944·Phase 3·Recruiting·Listed Sep 2025
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
for Systemic Lupus Erythematosus
Sites in Philadelphia +17 more locations
Sponsor: Cabaletta Bio
Sex: All·Age: 18 - 65
Code: NCT06121297·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
for Crohn's Disease
Sites in Philadelphia +14 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 2 - 17
Code: NCT05509777·Phase 3·Recruiting·Listed Aug 2022
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
for Myasthenia Gravis
Drug: Nipocalimab
Sites in Philadelphia, Hershey +6 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 2 - 17
Code: NCT05265273·Phase 2, Phase 3·Recruiting·Listed Mar 2022
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for Myasthenia Gravis
Sites in Philadelphia +9 more locations
Sponsor: Kyverna Therapeutics
Sex: All·Age: 18 - 75
Code: NCT06193889·Phase 2, Phase 3·Recruiting·Listed Jan 2024
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Guselkumab
Sites in Philadelphia +12 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 2 - 17
Code: NCT05923073·Phase 3·Recruiting·Listed Jun 2023
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
for Ulcerative Colitis
Sites in Philadelphia +10 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 2 - 19
Code: NCT04844606·Phase 3·Recruiting·Listed Apr 2021
BOOM-IBD2 Pivotal Clinical Trial
for Ulcerative Colitis
Sites in Philadelphia +16 more locations
Sponsor: Boomerang Medical
Sex: All·Age: 18 - 85
Code: NCT06571669·Recruiting·Listed Aug 2024
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Upadacitinib
Sites in Philadelphia +11 more locations
Sponsor: AbbVie
Sex: All·Age: 2 - 17
Code: NCT06332534·Phase 3·Recruiting·Listed Mar 2024
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
for Muscular Diseases
Sites in Philadelphia +12 more locations
Sponsor: Arcellx, Inc.
Sex: All·Age: 18+
Code: NCT06626919·Phase 1·Recruiting·Listed Oct 2024
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
for Healthy Participants
Drug: PF-07832837
Sites in Philadelphia +4 more locations
Sponsor: Pfizer
Sex: All·Age: 18 - 70·Accepts healthy volunteers
Code: NCT06564389·Phase 1·Recruiting·Listed Aug 2024
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
for Generalized Myasthenia Gravis
Sites in Philadelphia +3 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 65
Code: NCT06704269·Phase 1, Phase 2·Recruiting·Listed Nov 2024
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
for Psoriatic Arthritis
Drug: Upadacitinib
Sites in Philadelphia +2 more locations
Sponsor: CARE ARTHRITIS LTD.
Sex: All·Age: 18+
Code: NCT06454188·Phase 4·Recruiting·Listed Jun 2024
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
for Atopic Dermatitis
Sites in Philadelphia, Camp Hill +1 more location
Sponsor: Brexogen Inc.
Sex: All·Age: 18+
Code: NCT06055361·Phase 1·Recruiting·Listed Sep 2023
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
for Psoriasis
Sites in Philadelphia +2 more locations
Sponsor: SFA Therapeutics
Sex: All·Age: 18+
Code: NCT05642182·Phase 1·Recruiting·Listed Dec 2022
Duloxetine in Inflammatory Bowel Diseases
for Inflammatory Bowel Diseases
1 location in Philadelphia
Sponsor: University of Pennsylvania
Sex: All·Age: 24+
Code: NCT07431606·Phase 2·Recruiting·Listed Feb 2026
Central Vein Sign in Multiple Sclerosis Extension Study
for Multiple Sclerosis
Sites in Philadelphia +2 more locations
Sponsor: The Cleveland Clinic
Sex: All·Age: 18 - 65
Code: NCT07424027·Recruiting·Listed Feb 2026
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for Hematologic Malignancies
Sites in Philadelphia, Hershey +111 more locations
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All·Age: All ages
Code: NCT01351545·Recruiting·Listed May 2011
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
for Multiple Sclerosis
Sites in Philadelphia +12 more locations
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All·Age: 18 - 55
Code: NCT05285891·Phase 4·Recruiting·Listed Mar 2022
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
for Crohn Disease
Sites in Philadelphia, Pittsburgh +19 more locations
Sponsor: Connecticut Children's Medical Center
Sex: All·Age: 6 - 17
Code: NCT05781152·Phase 4·Recruiting·Listed Mar 2023
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
for Psoriatic Arthritis
Drug: Guselkumab
Sites in Philadelphia +13 more locations
Sponsor: University of Pennsylvania
Sex: All·Age: 18 - 80
Code: NCT05669833·Phase 3·Recruiting·Listed Jan 2023
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
for Systemic Lupus Erythematosus
1 location in Philadelphia
Sponsor: Stephan Grupp MD PhD
Sex: All·Age: 8 - 25
Code: NCT05029336·Phase 2·Recruiting·Listed Aug 2021
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
for Crohn Disease
Sites in Philadelphia +1 more location
Sponsor: Seattle Children's Hospital
Sex: All·Age: 8 - 21
Code: NCT06216899·Recruiting·Listed Jan 2024
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
for Myasthenia Gravis
Sites in Philadelphia +9 more locations
Sponsor: Ad scientiam
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT05564936·Recruiting·Listed Oct 2022
X-linked Moesin Associated Immunodeficiency
for Immune Deficiency
Sites in Philadelphia +2 more locations
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Sex: Male·Age: 4 - 80
Code: NCT06278337·Recruiting·Listed Feb 2024
Top Research Study Locations in Philadelphia
Researchers run research studies in Philadelphia, PA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Pennsylvania | Heart Failure, Opioid Use Disorder, Colorectal Cancer | 358 |
| Children's Hospital of Philadelphia | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Pediatric Cancer | 302 |
| Thomas Jefferson University Hospital | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 110 |
| Thomas Jefferson University | Focal Epilepsy, Advanced Melanoma, Cancer | 97 |
| Fox Chase Cancer Center | Breast Cancer, Cancer, Urothelial Carcinoma | 95 |
| Hospital of the University of Pennsylvania | Abdominal Aortic Aneurysm, Breast Cancer, Aortic Dissection | 87 |
| Temple University | Amyotrophic Lateral Sclerosis, COPD, Emphysema | 41 |
| The Children's Hospital of Philadelphia | Mitochondrial Diseases, Primary Mitochondrial Disease, 4H Syndrome | 40 |
| Temple University Hospital | Interstitial Lung Disease, Progressive Pulmonary Fibrosis, COPD | 35 |
| University of Pennsylvania/Abramson Cancer Center | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 31 |
| Pennsylvania Hospital | Stroke, Acute, Activity Restriction, Advanced Cancer | 28 |
| Penn Presbyterian Medical Center | Atrial Fibrillation, Heart Failure, ADHF | 26 |
| Abramson Cancer Center of the University of Pennsylvania | Breast Cancer, Advanced Solid Tumor, DLBCL - Diffuse Large B Cell Lymphoma | 25 |
| Jefferson Torresdale Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 23 |
| Saint Christopher's Hospital for Children | Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 22 |
| Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA | Parkinson Disease, Stress Disorders, Post-Traumatic, Alcohol Use Disorder | 18 |
| Sidney Kimmel Cancer Center at Thomas Jefferson University | Breast Cancer, Colorectal Cancer, Hormone Receptor Positive Breast Carcinoma | 16 |
| Drexel University | Autism Spectrum Disorder, Obesity, Anxiety | 13 |
| Penn Medicine | Hypertension, ALS, Allogeneic Transplantation | 13 |
| University of Pennsylvania Hospital | Chronic Lymphocytic Leukemia, Neoplasm Metastasis, Non-Hodgkin Lymphoma | 13 |
| GSK Investigational Site | Asthma, Connective Tissue Diseases, Gastrointestinal Neoplasms | 12 |
| Childrens Hospital of Philadelphia | Suicide, Cardiac Arrest (CA), Cardiopulmonary Resuscitation (CPR) | 12 |
| University of Pennsylvania, Abramson Cancer Center | Advanced Solid Tumor, Biliary Tract Cancer, Breast Cancer | 12 |
| Abramson Cancer Center at University of Pennsylvania | Cardiotoxicity, Renal Cell Carcinoma, AML, Adult | 10 |
| Thomas Jefferson University, Sidney Kimmel Cancer Center | Advanced Solid Tumor, Colorectal Cancer, Bladder Cancer | 10 |
Active & Upcoming Studies in Philadelphia (2026)
Recruiting trials in Philadelphia grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (556 active studies)
- Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment · Phase 1, Phase 2 · National Cancer Institute (NCI)
- The AYA Oncology Self-care Movement · Northwestern University
Neurology & pain (111 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease · Phase 4 · VA Office of Research and Development
Cardiovascular (110 active studies)
- UNDERSTANDING THE EFFECTS OF PULMONARY ARTERIAL HYPERPTENSION ON LEAN MUSCLE MASS-SUBSTUDY · University of Pennsylvania
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
Diabetes & metabolic (65 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
Mental health & behavior (49 active studies)
- NST-SPARK Open-Label Phase 1 STTR (IGNITE) · North Shore Therapeutics, Inc.
- Effect of cTBS on Startle and TMS-evoked BOLD · University of Pennsylvania
Pediatric (47 active studies)
- Bilevel Positive Airway Pressure (BPAP) for Severe Asthma · Columbia University
- Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). · Phase 2 · BrainChild Bio, Inc
HIV / STI (27 active studies)
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Eye & vision (23 active studies)
- Penn SICCA Follow-up Study · University of Pennsylvania
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) · Phase 1 · Genentech, Inc.
Vaccines (7 active studies)
- Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older · Phase 1, Phase 2 · Sanofi
- Flu Infection at UPHS · University of Pennsylvania
Common conditions studied in Philadelphia
- Breast Cancer (36 active studies)
- Cancer (25 active studies)
- Heart Failure (21 active studies)
- Ovarian Cancer (21 active studies)
- Prostate Cancer (21 active studies)
- Advanced Solid Tumor (18 active studies)
Leading research sponsors in Philadelphia
- University of Pennsylvania
- Abramson Cancer Center at Penn Medicine
- Children's Hospital of Philadelphia
- Thomas Jefferson University
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Philadelphia?
There are approximately 1,986 recruiting clinical trials in Philadelphia, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Philadelphia pay participants?
Most recruiting trials in Philadelphia compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Philadelphia?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Philadelphia?
The most common conditions under active study in Philadelphia include Breast Cancer (36), Cancer (25), Heart Failure (21), Ovarian Cancer (21), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Philadelphia?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Philadelphia on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Philadelphia?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Philadelphia?
Recruiting research sites in Philadelphia include University of Pennsylvania, Children's Hospital of Philadelphia, Thomas Jefferson University Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Philadelphia right now?
The largest active categories in Philadelphia are Cancer & tumors (556), Neurology & pain (111), Cardiovascular (110). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Pennsylvania
Pittsburgh, PA(1,242)Hershey, PA(268)Allentown, PA(127)Danville, PA(127)Bethlehem, PA(99)York, PA(94)Erie, PA(87)Wilkes-Barre, PA(78)Lancaster, PA(70)Monroeville, PA(65)Harrisburg, PA(58)Wynnewood, PA(52)Lewisburg, PA(50)Hazleton, PA(46)Willow Grove, PA(45)Mechanicsburg, PA(41)East Stroudsburg, PA(39)West Reading, PA(39)Greensburg, PA(35)Media, PA(35)Scranton, PA(34)Sayre, PA(33)Duncansville, PA(32)Uniontown, PA(32)Chambersburg, PA(31)Dickson City, PA(31)Chadds Ford, PA(29)University Park, PA(29)Lebanon, PA(28)DuBois, PA(27)Beaver, PA(24)Ephrata, PA(24)Gettysburg, PA(24)Pottsville, PA(24)West Chester, PA(24)Wyomissing, PA(24)Bala-Cynwyd, PA(23)Camp Hill, PA(23)Farrell, PA(23)Paoli, PA(23)Wexford, PA(23)Washington, PA(22)Easton, PA(21)Altoona, PA(20)Indiana, PA(20)Johnstown, PA(20)New Castle, PA(20)Seneca, PA(20)Butler, PA(19)Jefferson Hills, PA(19)Plymouth Meeting, PA(19)State College, PA(19)Abington, PA(18)Bryn Mawr, PA(18)Natrona Heights, PA(16)Smithfield, PA(16)Carlisle, PA(15)Cranberry Township, PA(15)Williamsport, PA(15)Horsham, PA(13)